Ralleigh G, Michell M J
Department of Radiology, King's College Hospital, London, UK.
Int J Clin Pract. 2002 Oct;56(8):583-7.
The introduction of mammographic screening has led to an increased number of impalpable in situ and invasive breast cancers. Image-guided percutaneous biopsy in these patients has advantages over surgical biopsy, primarily cost savings and reducing the number of operations required for definitive treatment. Image-guided breast biopsy is also useful in palpable lesions. Image-guided biopsy should be used in conjunction with full clinical and imaging work-up as part of the triple assessment protocol. Techniques available include fine needle aspiration, automated needle-gun core and vacuum assisted large core biopsy. Lesions visible on ultrasound are preferentially biopsied using ultrasound guidance, while those seen only mammographically are biopsied using stereotactic guidance. Major complications are rare following image-guided biopsy. In most cases further management can be decided based on the biopsy result. If there is discordance between clinical and imaging features and the biopsy result, image-guided percutaneous biopsy should be repeated or surgical biopsy may be required.
乳腺钼靶筛查的引入导致了不可触及的原位癌和浸润性乳腺癌数量增加。对这些患者进行影像引导下经皮活检比手术活检具有优势,主要体现在节省成本以及减少确定性治疗所需的手术次数。影像引导下乳腺活检在可触及病变中也很有用。影像引导活检应与全面的临床和影像学检查相结合,作为三联评估方案的一部分。可用的技术包括细针穿刺抽吸、自动针枪芯活检和真空辅助大芯活检。超声可见的病变优先采用超声引导进行活检,而仅在乳腺钼靶上可见的病变则采用立体定向引导进行活检。影像引导活检后严重并发症很少见。在大多数情况下,可以根据活检结果决定进一步的治疗方案。如果临床和影像学特征与活检结果不一致,应重复影像引导下经皮活检或可能需要进行手术活检。